SREN Stock Analysis: Swiss Re | SW
Insurance - Reinsurance | SW, Switzerland | Market Cap: 39.667m CHF | 12M Return: -2.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 104M
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Swiss Re AG is a global reinsurer founded in 1863 and headquartered in Zurich, Switzerland. The company operates through three main segments: Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions, offering risk transfer solutions across multiple lines including property, casualty, aviation, marine, cyber, and life and health products.
Swiss Re serves a broad client base that includes stock and mutual insurance companies, public sector and governmental entities, mid-sized and large corporations, and individuals. As a reinsurer, the company essentially provides insurance to insurance companies, helping primary insurers manage large or catastrophic risks by assuming portions of their underwriting exposure.
- P&C renewal pricing softens amid easing market conditions
- Major catastrophe losses pressure combined ratio
- Higher fixed income yields lift net investment income
| Net Income: 3.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.10 > 1.0 |
| NWC/Revenue: -208.2% < 20% (prev 21.13%; Δ -229.3% < -1%) |
| CFO/TA 0.02 > 3% & CFO 3.16b > Net Income 3.53b |
| Net Debt (6.23b) to EBITDA (13.5b): 0.46 < 3 |
| Current Ratio: 0.15 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (298.8m) vs prev 1.16% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 27.20% > 50% (prev 17.24%; Δ 9.96% > 0%) |
| Interest Coverage Ratio: 39.71 > 6 (EBIT TTM 13.5b / Interest Expense TTM 339.1m) |
| A: -0.55 (Total Current Assets 13.2b - Total Current Liabilities 87.1b) / Total Assets 134b |
| B: 0.21 (Retained Earnings 27.7b / Total Assets 134b) |
| C: 0.10 (EBIT TTM 13.5b / Avg Total Assets 131b) |
| D: 0.23 (Book Value of Equity 24.7b / Total Liabilities 109b) |
| Altman-Z'' = -2.01 = D |
| DSRI: 3.0 (Receivables 10.4b/624.0m, Revenue 35.5b/21.9b) |
| GMI: 1.0 (GM 100.0% / 100.0%) |
| AQI: 3.03 (AQ_t 0.90 / AQ_t-1 0.30) |
| SGI: 1.62 (Revenue 35.5b / 21.9b) |
| TATA: 0.00 (NI 3.53b - CFO 3.16b) / TA 134b) |
| Beneish M = 0.27 (Cap -4..+1) = D |
As of July 28, 2026, the stock is trading at CHF 136.45 with a total of 651,081 shares traded. Over the past week, the price has changed by +0.81%, over one month by +5.57%, over three months by +7.36% and over the past year by -2.08%.
Current recommended Stop Loss: 133.00 (which is 2.5% or 1.3 ATR below the current price).
Swiss Re has no consensus analysts rating.
Market Cap USD = 48.7b (39.7b CHF * 1.2277 CHF.USD)
P/E Trailing = 10.4832
P/E Forward = 8.5911
P/S = 0.9357
P/B = 1.8802
P/EG = 0.8009
Revenue TTM = 35.5b USD
EBIT TTM = 13.5b USD
EBITDA TTM = 13.5b USD
Long Term Debt = 8.54b USD (from longTermDebt, last quarter)
Short Term Debt = 294.8m USD (from shortTermDebt, last quarter)
Debt = 8.98b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.23b USD (calculated: Debt 8.98b - CCE 2.74b)
Enterprise Value = 54.9b USD (48.7b + Debt 8.98b - CCE 2.74b)
Interest Coverage Ratio = 39.71 (Ebit TTM 13.5b / Interest Expense TTM 339.1m)
EV/FCF = 17.36x (Enterprise Value 54.9b / FCF TTM 3.16b)
FCF Yield = 5.76% (FCF TTM 3.16b / Enterprise Value 54.9b)
FCF Margin = 8.91% (FCF TTM 3.16b / Revenue TTM 35.5b)
Net Margin = 9.93% (Net Income TTM 3.53b / Revenue TTM 35.5b)
Gross Margin = unknown ((Revenue TTM 35.5b - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 0.41 (Enterprise Value 54.9b / Total Assets 134b)
Interest Expense / Debt = 3.78% (Interest Expense 339.1m / Debt 8.98b)
Taxrate = 24.11% (1.11b / 4.62b)
NOPAT = 10.2b (EBIT 13.5b * (1 - 24.11%))
Current Ratio = 0.15 (Total Current Assets 13.2b / Total Current Liabilities 87.1b)
Debt / Equity = 0.36 (Debt 8.98b / totalStockholderEquity, last quarter 24.7b)
Debt / EBITDA = 0.46 (Net Debt 6.23b / EBITDA 13.5b)
Debt / FCF = 1.97 (Net Debt 6.23b / FCF TTM 3.16b)
Total Stockholder Equity = 23.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.70% (Net Income 3.53b / Total Assets 134b)
RoE = 15.01% (Net Income TTM 3.53b / Total Stockholder Equity 23.5b)
RoCE = 42.04% (EBIT 13.5b / Capital Employed (Equity 23.5b + L.T.Debt 8.54b))
RoIC = 22.54% (NOPAT 10.2b / Invested Capital 45.3b)
WACC = 6.13% (E(48.7b)/V(57.7b) * Re(6.73%) + D(8.98b)/V(57.7b) * Rd(3.78%) * (1-Tc(0.24)))
Discount Rate = 6.73% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -19.49 | Cagr: -0.01%
[DCF] Terminal Value 75.58% ; FCFF base≈3.15b ; Y1≈3.19b ; Y5≈3.44b
[DCF] Fair Price = 160.0 (EV 53.4b - Net Debt 6.23b = Equity 47.2b / Shares 294.9m; r=8.35% [WACC [floored]]; 5y FCF grow 1.08% → 2.50% )
EPS Correlation: 76.91 | EPS CAGR: 26.29% | SUE: 0.94 | # QB: 1
Revenue Correlation: -65.67 | Revenue CAGR: -22.29% | SUE: 3.42 | # QB: 1
EPS current Quarter (2026-06-30): EPS=4.01 | Chg30d=+3.86% | Revisions=+25% | Analysts=2
EPS next Quarter (2026-09-30): EPS=3.78 | Chg30d=-4.26% | Revisions=-25% | Analysts=2
EPS current Year (2026-12-31): EPS=16.05 | Chg30d=-1.02% | Revisions=+40% | GrowthEPS=+2.4% | GrowthRev=-1.0%
EPS next Year (2027-12-31): EPS=15.97 | Chg30d=-0.10% | Revisions=+0% | GrowthEPS=-0.5% | GrowthRev=+1.1%
[Analyst] Revisions Ratio: +22% (up=4, down=2)